Literature DB >> 18465151

Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.

Robert S Oakes1, Justin K Kirkham, Justin K Kirkhamm, Raoul D Nelson, Richard L Siegler.   

Abstract

Prior long-term retrospective studies have described renal sequelae in 25-50% of postdiarrheal hemolytic uremic syndrome (HUS) survivors, but the ability to predict the likelihood of chronic renal-related sequelae at the time of hospital discharge is limited. We surveyed 357 children in our HUS registry who survived an acute episode of post diarrheal HUS (D+HUS) and were without end-stage renal disease (ESRD) at the time of hospital discharge. Of the 357 patients surveyed, 159 had at least 1 year (mean 8.75 years) of follow-up. Of these, 90 individuals were identified as having had at least 1 day of oliguria, with 69 individuals having had at least 1 day of anuria. The incidences of renal-related sequelae [proteinuria, low glomerular filtration rate (GFR), and hypertension] were determined among experimental groups based on oliguria and anuria duration. One or more sequelae (e.g. proteinuria, low GFR, hypertension) was seen in 25 (36.2%) of those who had no recorded oliguria and 34 (37.8%) of those with no recorded anuria. The prevalence of chronic sequelae increased markedly in those with more than 5 days of anuria or 10 days of oliguria, with anuria being a better predictor than oliguria of most related sequelae. A particularly high incidence of hypertension was seen in patients with > 10 days of anuria (55.6%) in comparison with those with no anuria (8.9%) [odds ratio (OR) 12.8; 95% confidence interval (CI) 2.9-57.5]. Patients with > 10 days of anuria were also at substantially increased risk for low GFR and proteinuria (OR 35.2; 95% CI 5.1-240.5). These findings may help identify children who need periodic and extended follow-up after hospital discharge.

Entities:  

Mesh:

Year:  2008        PMID: 18465151     DOI: 10.1007/s00467-008-0799-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE).

Authors:  R J Hogg; R J Portman; D Milliner; K V Lemley; A Eddy; J Ingelfinger
Journal:  Pediatrics       Date:  2000-06       Impact factor: 7.124

2.  Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome.

Authors:  R L Siegler; M K Milligan; T H Burningham; R D Christofferson; S Y Chang; L B Jorde
Journal:  J Pediatr       Date:  1991-02       Impact factor: 4.406

3.  Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow.

Authors:  D Hüseman; J Gellermann; I Vollmer; I Ohde; S Devaux; J H Ehrich; G Filler
Journal:  Pediatr Nephrol       Date:  1999-10       Impact factor: 3.714

4.  Survey of haemolytic-uraemic syndrome in Queensland 1979-1995.

Authors:  Y Mizusawa; L A Pitcher; J R Burke; M C Falk; W Mizushima
Journal:  Med J Aust       Date:  1996-08-19       Impact factor: 7.738

5.  [Changing clinical course of hemolytic uremic syndrome in children].

Authors:  A Zurowska; Z Gockowska; P Czarniak; E Marczak
Journal:  Pol Merkur Lekarski       Date:  2000-04

6.  Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome.

Authors:  M G Caletti; G Gallo; C A Gianantonio
Journal:  Pediatr Nephrol       Date:  1996-12       Impact factor: 3.714

7.  Long-term follow-up of Czech children with D+ hemolytic-uremic syndrome.

Authors:  Kveta Bláhová; Jan Janda; Jiri Kreisinger; Eva Matejková; Anna Sedivá
Journal:  Pediatr Nephrol       Date:  2002-06       Impact factor: 3.714

8.  Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.

Authors:  M F Gagnadoux; R Habib; M C Gubler; J L Bacri; M Broyer
Journal:  Clin Nephrol       Date:  1996-07       Impact factor: 0.975

9.  Childhood haemolytic uraemic syndrome: long-term outcome and prognostic features.

Authors:  A Kelles; M Van Dyck; W Proesmans
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

10.  A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah.

Authors:  R L Siegler; A T Pavia; R D Christofferson; M K Milligan
Journal:  Pediatrics       Date:  1994-07       Impact factor: 7.124

View more
  25 in total

1.  A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network.

Authors:  Gianluigi Ardissino; Francesca Tel; Sara Testa; Fabio Paglialonga; Selena Longhi; Laura Martelli; Silvia Consolo; Damiano Picicco; Antonella Dodaro; Laura Daprai; Rosaria Colombo; Milena Arghittu; Michela Perrone; Giovanna Chidini; Stefano Scalia Catenacci; Isabella Cropanese; Dario Consonni
Journal:  Eur J Pediatr       Date:  2018-08-10       Impact factor: 3.183

2.  Blood urea nitrogen to serum creatinine ratio is an accurate predictor of outcome in diarrhea-associated hemolytic uremic syndrome, a preliminary study.

Authors:  Werner Keenswijk; Jill Vanmassenhove; Ann Raes; Evelyn Dhont; Johan Vande Walle
Journal:  Eur J Pediatr       Date:  2017-01-11       Impact factor: 3.183

Review 3.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

4.  Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.

Authors:  Ryan S McKee; David Schnadower; Phillip I Tarr; Jianling Xie; Yaron Finkelstein; Neil Desai; Roni D Lane; Kelly R Bergmann; Ron L Kaplan; Selena Hariharan; Andrea T Cruz; Daniel M Cohen; Andrew Dixon; Sriram Ramgopal; Annie Rominger; Elizabeth C Powell; Jennifer Kilgar; Kenneth A Michelson; Darcy Beer; Martin Bitzan; Christopher M Pruitt; Kenneth Yen; Garth D Meckler; Amy C Plint; Stuart Bradin; Thomas J Abramo; Serge Gouin; April J Kam; Abigail Schuh; Fran Balamuth; Tracy E Hunley; John T Kanegaye; Nicholas E Jones; Usha Avva; Robert Porter; Daniel M Fein; Jeffrey P Louie; Stephen B Freedman
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

5.  Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study.

Authors:  Lucas Percheron; Raluca Gramada; Stéphanie Tellier; Remi Salomon; Jérôme Harambat; Brigitte Llanas; Marc Fila; Emma Allain-Launay; Anne-Laure Lapeyraque; Valerie Leroy; Anne-Laure Adra; Etienne Bérard; Guylhène Bourdat-Michel; Hassid Chehade; Philippe Eckart; Elodie Merieau; Christine Piètrement; Anne-Laure Sellier-Leclerc; Véronique Frémeaux-Bacchi; Chloe Dimeglio; Arnaud Garnier
Journal:  Pediatr Nephrol       Date:  2018-03-23       Impact factor: 3.714

6.  Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center.

Authors:  Gia Oh; Keith K Lau
Journal:  Int Urol Nephrol       Date:  2011-11-25       Impact factor: 2.370

7.  Atypical hemolytic-uremic syndrome (HUS) with recovery after a long-lasting anuria: a case report.

Authors:  H Georgaki-Angelaki; N Stergiou; A Kapogiannis; I Orfanou; B Grapsa; E Roma
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

8.  Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.

Authors:  Deborah J Stearns-Kurosawa; Valta Collins; Scott Freeman; Diann Debord; Kiyotaka Nishikawa; Sun-Young Oh; Caitlin S Leibowitz; Shinichiro Kurosawa
Journal:  Pediatr Nephrol       Date:  2011-05-21       Impact factor: 3.714

Review 9.  HUS and TTP in Children.

Authors:  Howard Trachtman
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

Review 10.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.